Gastrointestinal Cancer
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus.
Showing 1–16 of 18 results
-
AVASTIN (bevacizumab) Solution for intravenous infusion. Initial U.S. Approval: 2004
Read more -
AYVAKIT (avapritinib) tabletsAYVAKIT (avapritinib) tablets, for oral use. Initial U.S. Approval: 2020
Read more -
BALVERSA (erdafitinib) tablets
Read more -
Bevacizumab Injection. Initial U.S. Approval: 2004
Read more -
CYRAMZA (ramucirumab) injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
Entocir (Budesonide) Capsules
Read more -
FRUZAQLA (fruquintinib) capsules
Read more -
IMJUDO (tremelimumab-actl) injection
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014
Read more -
LONSURF (trifluridine and tipiracil) tablets, for oral use. Initial U.S. Approval: 2015
Read more -
LYNPARZA (olaparib) tablets
Read more -
LYTGOBI (futibatinib) tablets
Read more -
ONIVYDE (irinotecan liposome injection), for intravenous use. Initial U.S. Approval: 1996
Read more -
PADCEV (enfortumab vedotin-ejfv) for injection
Read more -
PEMAZYRE (pemigatinib) tablets, for oral use. Initial U.S. Approval: 2020
Read more -
QINLOCK (ripretinib) tablets
Read more
